A French company specialized in innovative medical devices has developed a rapid occlusion system specifically designed to quickly obtain arterial haemostasis, and reduce blood loss during vascular reconstruction interventions. Pre-clinical studies have shown superiority over conventional ligation technique thus significantly improving surgical outcome. The company is looking for a licensing partner to take over its technology and jointly bring it to market.